News and Trends 29 Nov 2022
Touchlight receives new grant to further develop doggybone DNA vaccine platform
UK-based biotechnology company, Touchlight, has received a new grant from the Bill & Melinda Gates Foundation. The company will use…
Gates Foundation
- Latest Posts
News and Trends 30 Aug 2022
Bactolife receives $5M in new funding to address gut infections worldwide
Bactolife has received an investment of $5 million from The Bill & Melinda Gates Foundation to accelerate the use of…
News and Trends 12 Jul 2022
First patient receives new immunotherapy drug for HIV in clinical trial
A new class of bispecific protein immunotherapy, being developed for patients with human immunodeficiency virus (HIV) infection, has been given…
News and Trends 30 Jul 2021
British Diagnostics Biotech Becomes Social Enterprise After Acquisition
UK rapid diagnostics company Mologic will convert into a social enterprise after being acquired by a group of philanthropic funds…
ADVERTISEMENT
More News! 29 Nov 2019
MedinCell Granted €17M to Develop Cheap Long-Acting Contraception
The French company MedinCell has received a €17.3M ($19M) grant from the Bill and Melinda Gates Foundation to advance its…
More News! 12 Jun 2019
Evotec to Reduce the Burden of Tuberculosis Treatment with €21M Grant
The Bill and Melinda Gates Foundation has granted the German biotech Evotec €21M ($23.8M) to discover drug combinations that can…
News and Trends 26 Jul 2017
German Biotech Publishes First-in-Human Data on Rabies mRNA Vaccine
CureVac has published proof-of-concept data for an mRNA rabies vaccine that could open the door for a new generation of…
News and Trends 1 Dec 2016
UPDATE: The HIV Frontier starts Phase III Vaccine trials in South Africa
Update (01/12/2016): The HVTN 702 trial has been started, making it the first HIV vaccine efficacy study in 7 years…
News and Trends 10 Jun 2016
Gates Foundation is funding EU Biotech to make Vaccines more affordable
Batavia Biosciences has won a €3.3M grant from the Gates Foundation, to fund new research in making cell culture cheaper -…
News and Trends 1 Jul 2015
mRNA Therapies: CureVac Outperformed the Money Magnet Moderna
Everybody has already heard about Boston-based Moderna Therapeutics, the most highly valued venture-backed private Biotech, but CureVac, its German competitor, remains much more understated. This could…